Select Your Region
LACTEL® 50:50 DL-PLGE, IV 0.76-0.94 is an ester-terminated lactide-glycolide-containing copolymer (CAS No. 26780-50-7) with an inherent viscosity of 0.76─0.94 dL/g in HFIP and a degradation time of 3 months max.
Evonik's LACTEL® 50:50 DL-PLGE, IV 0.76-0.94 is a versatile pellatized excipient polymer with an ester terminated lactide-glycolide base with a mol ratio of 50:50. Manufactured using a streamlined process to produce a cost-effective PLGA copolymer, Evonik's LACTEL® 50:50 DL-PLGE, IV 0.76-0.94 is non-solvent purified and formulated with no-added preservatives. It is commonly recommended for use in the formulation of long-acting injectable formulations in veterinary medicine and human generic drug formulations, exhibiting excellent compatibility with a range of pharmaceutical substance types, including peptides, proteins, nanoparticles, and microparticles.
Physical state: Solid
Form: Granules
Color: White to light tan
Inherent viscosity (IV) dL/g: 0.76─0.94 (in HFIP)
Degradation time: <3 months
Density (g/mL): 1.34
Tensile Strength (psi): 6000─8000
Elongation (%): 3─10
Modulus (psi): 2─4x10⁵
CAS No. 26780-50-7
Primary Chemistry:
Poly(DL-lactide-co-glycolide)
Human generic drug formulations
Long-acting injectable formulations
Price sensitive applications
veterinary medicine
We’ve detected that you are located in a different region than the region selected on the website. Would you like to change your region?
Current Region: English - United States